Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLT COVID-19 vaccine

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Jul 08, 2022 7:55pm

233 Views

Post# 34812293

RE:TLT COVID-19 vaccine

ScienceFirst wrote: I just read today that Canada has only one Canadian-made vaccine (MEDICAGO).

So if we get the green light from PHAC-NML, we would become the 2nd one. That's interesting.

Truly a wildcard if this Covid angle works out. Why I'm still a very excited investor.

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading